Terms: = Sarcomas AND EML4, ENSG00000143924, 27436 AND Prognosis
6 results:
1. NTRK -Rearranged Uterine sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
Costigan DC; Nucci MR; Dickson BC; Chang MC; Song S; Sholl LM; Hornick JL; Fletcher CDM; Kolin DL
Am J Surg Pathol; 2022 Oct; 46(10):1415-1429. PubMed ID: 35713627
[TBL] [Abstract] [Full Text] [Related]
2. A novel case of an aggressive superficial spindle cell sarcoma in an adult resembling fibrosarcomatous dermatofibrosarcoma protuberans and harboring an eml4-NTRK3 fusion.
Olson N; Rouhi O; Zhang L; Angeles C; Bridge J; Lopez-Terrada D; Royce T; Linos K
J Cutan Pathol; 2018 Dec; 45(12):933-939. PubMed ID: 30175468
[TBL] [Abstract] [Full Text] [Related]
3. A systematic review of targeted agents for non-small cell lung cancer.
Vestergaard HH; Christensen MR; Lassen UN
Acta Oncol; 2018 Feb; 57(2):176-186. PubMed ID: 29172833
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma.
Li X; Wang D; Zhao Q; Ren D; Ren F; Chen G; Liu H; Chen J
Sci Rep; 2017 Jun; 7(1):3947. PubMed ID: 28638113
[TBL] [Abstract] [Full Text] [Related]
5. Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, eml4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.
Ulivi P; Chiadini E; Dazzi C; Dubini A; Costantini M; Medri L; Puccetti M; Capelli L; Calistri D; Verlicchi A; Gamboni A; Papi M; Mariotti M; De Luigi N; Scarpi E; Bravaccini S; Turolla GM; Amadori D; Crinò L; Delmonte A
Clin Lung Cancer; 2016 Sep; 17(5):384-390. PubMed ID: 26712101
[TBL] [Abstract] [Full Text] [Related]
6. CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes.
Koga T; Takeshita M; Ijichi K; Yano T; Maehara Y; Sueishi K
Hum Pathol; 2013 Jul; 44(7):1382-90. PubMed ID: 23415374
[TBL] [Abstract] [Full Text] [Related]